Covered recipient · General Payments record
CHARLES FOUCAR
Allopathic & Osteopathic Physicians Internal Medicine Hematology
General Payments · PY2025
$10,828.75
- Reported across 8 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $10,350.00 | 4 |
| Food and Beverage | $478.75 | 4 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $5,730.00 | 2 |
| TAIHO ONCOLOGY, INC. | $2,573.46 | 2 |
| Stemline Therapeutics Inc. | $2,170.00 | 1 |
| Janssen Research & Development, LLC | $146.14 | 1 |
| Celgene Corporation | $134.99 | 1 |
| Genentech USA, Inc. | $74.16 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $10,828.75 | 8 |
Payment records · PY2025 (8)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Celgene Corporation | $134.99 | 06/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184700265 | CMS |
| E.R. Squibb & Sons, L.L.C. | $2,865.00 | 08/22/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1184700251 | CMS |
| E.R. Squibb & Sons, L.L.C. | $2,865.00 | 09/11/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1184700263 | CMS |
| Genentech USA, Inc. | $74.16 | 12/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1211501767 | CMS |
| Janssen Research & Development, LLC | $146.14 | 11/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1173801357 | CMS |
| Stemline Therapeutics Inc. | $2,170.00 | 05/02/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1244091240 | CMS |
| TAIHO ONCOLOGY, INC. | $2,450.00 | 01/12/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1211413824 | CMS |
| TAIHO ONCOLOGY, INC. | $123.46 | 10/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1211404074 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.